Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1999
05/12/1999EP0915101A1 New synthetic polypeptide
05/12/1999EP0915099A1 Antiparallel oligopeptides and hydrophobically complementary oligopeptides, matrices containing them and use thereof in the purification and detection of subtypes of alpha interferon
05/12/1999EP0915088A1 D-Proline derivatives
05/12/1999EP0914831A2 Biological product for preventive or therapeutic oral administration against canine parvovirosis
05/12/1999EP0914830A1 Neovascularization inhibitor containing tissue factor pathway inhibitor
05/12/1999EP0914829A1 Preventives and/or remedies for multiple organ failure
05/12/1999EP0914828A2 Use of des-aspartate-angiotensin I
05/12/1999EP0914827A1 Ophthalmic drug compositions
05/12/1999EP0914826A1 Wound healing accelerators
05/12/1999EP0914614A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrP?c AND PrP?sc
05/12/1999EP0914460A1 Vehicle for the transport of molecular substances
05/12/1999EP0914459A2 Adenoviral mediated gene transfer in adipocytes and related implants
05/12/1999EP0914453A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF
05/12/1999EP0914452A2 Novel ptp20, pcp-2, bdp1, clk and sirp proteins and related products and methods
05/12/1999EP0914450A1 MITOGEN-ACTIVATED PROTEIN KINASE p38-2 AND METHODS OF USE THEREFOR
05/12/1999EP0914448A1 Lipid kinase
05/12/1999EP0914446A2 Cytochrome p450 expression in enterobacteria
05/12/1999EP0914443A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
05/12/1999EP0914437A2 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin
05/12/1999EP0914435A1 Hybrid interferon compositions and methods of use
05/12/1999EP0914433A2 Kv potassium channel polypeptides and polynucleotides
05/12/1999EP0914432A2 Secreted proteins and polynucleotides encoding them
05/12/1999EP0914431A2 Truncated soluble tumor necrosis factor type-i and type-ii receptors
05/12/1999EP0914430A2 Polynucleotides from human fetal brain encoding secreted proteins
05/12/1999EP0914429A1 Polynucleotides encoding secreted proteins from human pbmc
05/12/1999EP0914428A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
05/12/1999EP0914426A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases
05/12/1999EP0914423A2 Inhibition of hiv-1 replication by antisense rna expression
05/12/1999EP0914422A1 Mammalian genes involved in viral infection and tumor suppression
05/12/1999EP0914421A2 Hepatitis c virus ribozymes
05/12/1999EP0914417A2 Human dnase ii
05/12/1999EP0914415A1 Method and compositions for obtaining mature dendritic cells
05/12/1999EP0914414A1 Laminin 5 for growth of pancreatic islet cells
05/12/1999EP0914347A2 A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function
05/12/1999EP0914346A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FC$g(a) RECEPTOR ANTIBODIES
05/12/1999EP0914345A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2)
05/12/1999EP0914343A1 Nucleotide sequence typical for a deletion of proto-oncogene ret in exon 11
05/12/1999EP0914342A2 Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth
05/12/1999EP0914341A1 Antagonists of intestinotrophic glp-2 peptides
05/12/1999EP0914340A1 hGH-RH(1-29)NH 2? ANALOGUES HAVING ANTAGONISTIC ACTIVITY
05/12/1999EP0914339A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
05/12/1999EP0914338A2 Cell growth regulatory genes
05/12/1999EP0914337A2 Secreted proteins
05/12/1999EP0914336A2 Secreted proteins
05/12/1999EP0914334A1 Process and intermediates for the synthesis of lhrh antagonists
05/12/1999EP0914333A1 Peptide derivatives
05/12/1999EP0914332A1 Isoquinolines useful as analgesics
05/12/1999EP0914331A1 Neuroactive peptides
05/12/1999EP0914330A1 Novel compounds
05/12/1999EP0914328A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE
05/12/1999EP0914327A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE
05/12/1999EP0914325A1 Modulators of the function of fas receptors and other proteins
05/12/1999EP0914324A2 Specific inhibitors of dna methyltransferase enzyme
05/12/1999EP0914202A1 Preservation by foam formation
05/12/1999EP0914168A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides
05/12/1999EP0914166A1 Methods of terminal sterilization of biological products
05/12/1999EP0914163A1 Novel processes implementing selective immune down regulation (sidr)
05/12/1999EP0914158A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
05/12/1999EP0914157A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease
05/12/1999EP0914155A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
05/12/1999EP0914150A1 Recombinant neospora antigens and their uses
05/12/1999EP0914148A1 Treatment of partial growth hormone insensitivity syndrome
05/12/1999EP0914147A1 Atrial natriuretic peptide (anp) as an additive to peritoneal dialysis solutions
05/12/1999EP0914146A1 Morphogen treatment for chronic renal failure
05/12/1999EP0914145A1 Methods of controlling axonal growth
05/12/1999EP0914144A1 Therapeutic uses of bpi protein products for human meningococcemia
05/12/1999EP0914143A1 Medicinal cyclosporin-a aerosol solution formulation
05/12/1999EP0914142A1 Peptides with increased binding affinity for hla molecules
05/12/1999EP0914141A1 Stabilized antihepatitis-b vaccine tablets
05/12/1999EP0914140A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof
05/12/1999EP0914131A1 Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
05/12/1999EP0914123A1 Prodrugs of thalidomide and methods for using same as modulators of t-cell function
05/12/1999EP0914114A1 Methods of treating type i hypersensitivity using monophosphoryl lipid a
05/12/1999EP0914096A1 Microparticles and their use in wound therapy
05/12/1999EP0914095A1 Method for fabricating polymer-based controlled-release devices
05/12/1999EP0914094A1 Materials and methods for making improved liposome compositions
05/12/1999EP0914081A1 Storage stable dentifrice composition containing casein glycomacropeptide
05/12/1999EP0914043A1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
05/12/1999EP0914041A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides
05/12/1999EP0883692A4 Methods for producing and analyzing biopolymer ladders
05/12/1999EP0808162B1 Use of carbazole compounds for the manufacture of a medicament for the treatment of congestive heart failure
05/12/1999EP0789710B1 Peptides for anti-allergy treatment
05/12/1999EP0754230B1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
05/12/1999EP0739354B1 Compositions and methods using unbound mpl receptor for stimulating platelet production
05/12/1999EP0733067B1 N-terminally chemically modified protein compositions and methods
05/12/1999EP0725786B1 Novel salts of amino glycosides
05/12/1999EP0642795B1 Remedy for cystic fibrosis
05/12/1999EP0627900B1 Use of injectable collagen biomaterials for the repair and augmentation of the anal sphincters
05/12/1999EP0592553B1 Pla2 inhibitory compounds
05/12/1999EP0481000B1 Receptors for fibroblast growth factors
05/12/1999EP0444081B1 Pharmaceutical preparation
05/12/1999DE19840875A1 Tumor-suppressing protein conductin
05/12/1999DE19747719A1 Genetic therapy of bone disorders by expressing proteins
05/12/1999CN1216584A Immunity to trypanosomatids species
05/12/1999CN1216582A Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
05/12/1999CN1216551A Novel peptides suitable for use in antigen specific immunosuppressive therapy
05/12/1999CN1216550A Anti-microbial protein
05/12/1999CN1216549A Antipathogenic peptides and compositions comprising them
05/12/1999CN1216472A A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
05/12/1999CN1216471A Stabilized antihepatitis-B vaccine tablets
1 ... 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 ... 3163